Radical radiotherapy for inoperable non-small cell lung cancer

Wendy JA Anderson, JJA McAleer, S Stranex, Gordon James Prescott

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We set out to determine the factors that predict the outcome of conventional radical radiotherapy for inoperable non-small cell lung cancer. A retrospective casenote review was carried out of all 69 patients treated between 1986 and 1992 at the Northern Ireland Centre for Clinical Oncology, Belfast, with radical radiotherapy for inoperable non-small cell lung cancer. The tumour dose ranged from 45 Gy to 67.5 Gy, delivered in 15-30 fractions, 5 days per week over 3-6 weeks. All patients were followed up for 5 years.
The disease was TNM Stage T-1-T4N0-N2M0. The majority of rumours (51) were squamous. Overall survival was 63.8% (44-patients; 95% confidence interval (CT) 51.3-75.2) at one year; median survival was 16 months and 5-year survival was 13% (nine patients; 95% CI 6.1-23.3). Five-year survival for the 36 patients with stage T-1 or T-2 disease was 5.6% (2 patients). Five-year survival for the 33 patients with stage T-3 or T-4 disease, all with tumours at or near the carina, was 21.2% (seven patients). A WHO performance status of 0 or 1 (P = 0.03, Cox proportional hazards model) was associated with a better chance of survival.
Original languageEnglish
Pages (from-to)48-52
Number of pages5
JournalClinical Oncology
Volume12
Issue number1
DOIs
Publication statusPublished - 2000

Fingerprint

Non-Small Cell Lung Carcinoma
Radiotherapy
Survival
Northern Ireland
Medical Oncology
Proportional Hazards Models
Neoplasms
Confidence Intervals

Keywords

  • inoperable
  • non-small cell lung cancer
  • radical radiotherapy

Cite this

Radical radiotherapy for inoperable non-small cell lung cancer. / Anderson, Wendy JA; McAleer, JJA; Stranex, S; Prescott, Gordon James.

In: Clinical Oncology, Vol. 12, No. 1, 2000, p. 48-52.

Research output: Contribution to journalArticle

Anderson, Wendy JA ; McAleer, JJA ; Stranex, S ; Prescott, Gordon James. / Radical radiotherapy for inoperable non-small cell lung cancer. In: Clinical Oncology. 2000 ; Vol. 12, No. 1. pp. 48-52.
@article{b573c11ebd474239951c12c6b4c1f4f2,
title = "Radical radiotherapy for inoperable non-small cell lung cancer",
abstract = "We set out to determine the factors that predict the outcome of conventional radical radiotherapy for inoperable non-small cell lung cancer. A retrospective casenote review was carried out of all 69 patients treated between 1986 and 1992 at the Northern Ireland Centre for Clinical Oncology, Belfast, with radical radiotherapy for inoperable non-small cell lung cancer. The tumour dose ranged from 45 Gy to 67.5 Gy, delivered in 15-30 fractions, 5 days per week over 3-6 weeks. All patients were followed up for 5 years. The disease was TNM Stage T-1-T4N0-N2M0. The majority of rumours (51) were squamous. Overall survival was 63.8{\%} (44-patients; 95{\%} confidence interval (CT) 51.3-75.2) at one year; median survival was 16 months and 5-year survival was 13{\%} (nine patients; 95{\%} CI 6.1-23.3). Five-year survival for the 36 patients with stage T-1 or T-2 disease was 5.6{\%} (2 patients). Five-year survival for the 33 patients with stage T-3 or T-4 disease, all with tumours at or near the carina, was 21.2{\%} (seven patients). A WHO performance status of 0 or 1 (P = 0.03, Cox proportional hazards model) was associated with a better chance of survival.",
keywords = "inoperable, non-small cell lung cancer, radical radiotherapy",
author = "Anderson, {Wendy JA} and JJA McAleer and S Stranex and Prescott, {Gordon James}",
year = "2000",
doi = "10.1053/clon.2000.9110 |",
language = "English",
volume = "12",
pages = "48--52",
journal = "Clinical Oncology",
issn = "0936-6555",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Radical radiotherapy for inoperable non-small cell lung cancer

AU - Anderson, Wendy JA

AU - McAleer, JJA

AU - Stranex, S

AU - Prescott, Gordon James

PY - 2000

Y1 - 2000

N2 - We set out to determine the factors that predict the outcome of conventional radical radiotherapy for inoperable non-small cell lung cancer. A retrospective casenote review was carried out of all 69 patients treated between 1986 and 1992 at the Northern Ireland Centre for Clinical Oncology, Belfast, with radical radiotherapy for inoperable non-small cell lung cancer. The tumour dose ranged from 45 Gy to 67.5 Gy, delivered in 15-30 fractions, 5 days per week over 3-6 weeks. All patients were followed up for 5 years. The disease was TNM Stage T-1-T4N0-N2M0. The majority of rumours (51) were squamous. Overall survival was 63.8% (44-patients; 95% confidence interval (CT) 51.3-75.2) at one year; median survival was 16 months and 5-year survival was 13% (nine patients; 95% CI 6.1-23.3). Five-year survival for the 36 patients with stage T-1 or T-2 disease was 5.6% (2 patients). Five-year survival for the 33 patients with stage T-3 or T-4 disease, all with tumours at or near the carina, was 21.2% (seven patients). A WHO performance status of 0 or 1 (P = 0.03, Cox proportional hazards model) was associated with a better chance of survival.

AB - We set out to determine the factors that predict the outcome of conventional radical radiotherapy for inoperable non-small cell lung cancer. A retrospective casenote review was carried out of all 69 patients treated between 1986 and 1992 at the Northern Ireland Centre for Clinical Oncology, Belfast, with radical radiotherapy for inoperable non-small cell lung cancer. The tumour dose ranged from 45 Gy to 67.5 Gy, delivered in 15-30 fractions, 5 days per week over 3-6 weeks. All patients were followed up for 5 years. The disease was TNM Stage T-1-T4N0-N2M0. The majority of rumours (51) were squamous. Overall survival was 63.8% (44-patients; 95% confidence interval (CT) 51.3-75.2) at one year; median survival was 16 months and 5-year survival was 13% (nine patients; 95% CI 6.1-23.3). Five-year survival for the 36 patients with stage T-1 or T-2 disease was 5.6% (2 patients). Five-year survival for the 33 patients with stage T-3 or T-4 disease, all with tumours at or near the carina, was 21.2% (seven patients). A WHO performance status of 0 or 1 (P = 0.03, Cox proportional hazards model) was associated with a better chance of survival.

KW - inoperable

KW - non-small cell lung cancer

KW - radical radiotherapy

U2 - 10.1053/clon.2000.9110 |

DO - 10.1053/clon.2000.9110 |

M3 - Article

VL - 12

SP - 48

EP - 52

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0936-6555

IS - 1

ER -